Mirion Technologies (MIR) and Its Peers Head-To-Head Analysis

Mirion Technologies (NYSE:MIR – Get Rating) is one of 16 public companies in the “Measuring & controlling devices, not elsewhere classified” industry, but how does it contrast to its competitors? We will compare Mirion Technologies to related companies based on the strength of its analyst recommendations, dividends, profitability, valuation, institutional ownership, risk and earnings.

Earnings & Valuation

This table compares Mirion Technologies and its competitors gross revenue, earnings per share and valuation.

	Gross Revenue	Net Income	Price/Earnings Ratio
Mirion Technologies	$717.80 million	-$276.90 million	-4.76
Mirion Technologies Competitors	$4.51 billion	$623.14 million	5.88

Mirion Technologies’ competitors have higher revenue and earnings than Mirion Technologies. Mirion Technologies is trading at a lower price-to-earnings ratio than its competitors, indicating that it is currently more affordable than other companies in its industry.

Volatility and Risk

Mirion Technologies has a beta of 0.55, suggesting that its stock price is 45% less volatile than the S&P 500. Comparatively, Mirion Technologies’ competitors have a beta of 1.03, suggesting that their average stock price is 3% more volatile than the S&P 500.

Analyst Recommendations

This is a summary of recent ratings and target prices for Mirion Technologies and its competitors, as reported by MarketBeat.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Mirion Technologies	0	0	3	0	3.00
Mirion Technologies Competitors	75	434	768	13	2.56

Mirion Technologies currently has a consensus target price of $11.00, indicating a potential upside of 51.10%. As a group, “Measuring & controlling devices, not elsewhere classified” companies have a potential upside of 14.19%. Given Mirion Technologies’ stronger consensus rating and higher possible upside, analysts clearly believe Mirion Technologies is more favorable than its competitors.

Institutional and Insider Ownership

83.4% of Mirion Technologies shares are owned by institutional investors. Comparatively, 62.2% of shares of all “Measuring & controlling devices, not elsewhere classified” companies are owned by institutional investors. 2.7% of Mirion Technologies shares are owned by insiders. Comparatively, 12.0% of shares of all “Measuring & controlling devices, not elsewhere classified” companies are owned by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company is poised for long-term growth.

Profitability

This table compares Mirion Technologies and its competitors’ net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
Mirion Technologies	-39.44%	2.71%	1.52%
Mirion Technologies Competitors	-18.13%	-32.19%	-5.24%

Summary

Mirion Technologies competitors beat Mirion Technologies on 7 of the 13 factors compared.

About Mirion Technologies

(Get Rating)

Mirion Technologies, Inc. provides radiation detection, measurement, analysis, and monitoring products and services in the United States, Canada, the United Kingdom, France, Germany, Finland, China, Belgium, Netherlands, Estonia, and Japan. It operates through two segments, Medical and Industrial. The medical segment offers radiation oncology quality assurance and dosimetry solutions; patient safety solutions for diagnostic imaging and radiation therapy centers; radiation therapy quality assurance solutions for calibrating and verifying imaging and treatment accuracy; and radionuclide therapy products for nuclear medicine applications, such as shielding, product handling, medical imaging furniture, and rehabilitation products. This segment supports applications in medical diagnostics, cancer treatment, practitioner safety, and rehabilitation. The Industrial segment focuses on addressing critical radiation safety, measurement, and analysis applications; and provides personal radiation detection, identification equipment, and analysis tools. The company's products and solutions also include nuclear medicines, dosimeters, contamination and clearance monitors, reactor instrumentation and control equipment and systems, medical and industrial imaging systems and related accessories, alpha spectroscopy instruments, alpha/beta counting instruments, and gamma spectroscopy detector systems; and electrical penetration, cancer diagnostics, software, and other services. It serves hospitals, clinics and urgent care facilities, dental and veterinary offices, radiation treatment facilities, OEMs for radiation therapy, laboratories, military organizations, government agencies, industrial companies, power and utility companies, reactor design firms, and NPPs. The company was formerly known as Global Monitoring Systems, Inc. and changed its name to Mirion Technologies, Inc. in January 2006. Mirion Technologies, Inc. was incorporated in 2005 and is headquartered in Atlanta, Georgia.